Strategic Partnerships

Connect With Bionews

Whether you're exploring media solutions, patient research, or clinical trial support, our team will help you find the right path to reaching rare disease communities with trust and precision.

How We Help Partners

Media & Advertising

Reach verified rare disease audiences across 50+ communities

Market Research & Insights

Access real-world patient perspectives through RareSignal intelligence

Clinical Trial Recruitment

Connect with engaged, diagnosis-confirmed patients ready to participate

Community Advocacy

Sponsored storytelling, patient collaborations, and awareness initiatives.

Editorial & Content

Sponsored content, patient stories, and disease education

HCP Engagement

Reach and engage specialist HCPs across rare disease communities

Why Partner With Bionews?

We're the largest network of rare disease patient communities — and the only platform where engagement is driven by lived experience.

1.5M+

Monthly engaged patients

95%

Diagnosis-confirmed audience

3–5×

Industry-average engagement

7 min

Average time on site

Trusted By

Top 20 pharma companies
Leading rare disease biotechs
Major clinical research organizations
Patient advocacy groups worldwide

"Bionews gave us access to a patient population we simply couldn't reach through traditional channels — with engagement rates that exceeded every benchmark."

— VP of Patient Engagement, Top 10 Pharma

Tell Us About Your Goals

Share some details and our partnerships team will follow up within one business day.

By submitting a request you may receive Bionews news, product updates, insights, and event emails.

Are You a Patient or Caregiver?

Our community sites offer disease-specific news, resources, and forums created by and for people living with rare diseases.

Explore Our Communities →

50+

Rare Disease Communities